PMC:7212965 / 40177-40568
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T88 | 344-351 | Body_part | denotes | stomach | http://purl.org/sig/ont/fma/fma7148 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T68 | 344-351 | Body_part | denotes | stomach | http://purl.obolibrary.org/obo/UBERON_0000945 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T207 | 263-271 | Disease | denotes | diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
| T208 | 382-390 | Disease | denotes | diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T81 | 0-2 | Chemical | denotes | GI | http://purl.obolibrary.org/obo/CHEBI_73907 |
| T82 | 64-69 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T83 | 153-172 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T84 | 153-162 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T85 | 163-172 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T180 | 205-211 | Phenotype | denotes | nausea | http://purl.obolibrary.org/obo/HP_0002018 |
| T181 | 233-241 | Phenotype | denotes | vomiting | http://purl.obolibrary.org/obo/HP_0002013 |
| T182 | 263-271 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
| T183 | 293-313 | Phenotype | denotes | abdominal discomfort | http://purl.obolibrary.org/obo/HP_0002027 |
| T184 | 382-390 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T253 | 0-391 | Sentence | denotes | GI adverse events were most common among those in the treatment group, and were the primary reason for medication discontinuation; of patients receiving lopinavir/ritonavir, there were 9.5% (9 of 99) with nausea, 6.3% (6 of 99) with vomiting, 4.2% (4 of 99) with diarrhea, 4.2% (4 of 99) with abdominal discomfort, 4.2% (4 of 99) with reported stomach ache, and 4.2% (4 of 99) with diarrhea. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1142 | 0-2 | Gene | denotes | GI | Gene:2770 |
| 1145 | 134-142 | Species | denotes | patients | Tax:9606 |
| 1150 | 153-172 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 1155 | 205-211 | Disease | denotes | nausea | MESH:D009325 |
| 1156 | 233-241 | Disease | denotes | vomiting | MESH:D014839 |
| 1157 | 263-271 | Disease | denotes | diarrhea | MESH:D003967 |
| 1158 | 344-356 | Disease | denotes | stomach ache | MESH:D063806 |
| 1159 | 382-390 | Disease | denotes | diarrhea | MESH:D003967 |